963 related articles for article (PubMed ID: 32161398)
61. Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response.
Wan D; Jiang W; Hao J
Front Immunol; 2020; 11():615. PubMed ID: 32411126
[TBL] [Abstract][Full Text] [Related]
62. Immunologically augmented cancer treatment using modern radiotherapy.
Durante M; Reppingen N; Held KD
Trends Mol Med; 2013 Sep; 19(9):565-82. PubMed ID: 23831337
[TBL] [Abstract][Full Text] [Related]
63. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
[TBL] [Abstract][Full Text] [Related]
64. [Correlation between Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Signaling Pathway and Non-infectious Diseases].
Yu HX; Rui HY; Han ZQ; Li RC; Liu LL; Xue L; Chen YG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):661-667. PubMed ID: 36065699
[TBL] [Abstract][Full Text] [Related]
65. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
Front Immunol; 2021; 12():676922. PubMed ID: 34335575
[TBL] [Abstract][Full Text] [Related]
66. Neuroinflammation and the cGAS-STING pathway.
Chin AC
J Neurophysiol; 2019 Apr; 121(4):1087-1091. PubMed ID: 30673358
[TBL] [Abstract][Full Text] [Related]
67. Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma.
Zhu C; Li J; Yao M; Fang C
BMC Oral Health; 2021 Oct; 21(1):506. PubMed ID: 34625078
[TBL] [Abstract][Full Text] [Related]
68. Cancer cell-autonomous cGAS-STING response confers drug resistance.
Lv QM; Lei HM; Wang SY; Zhang KR; Tang YB; Shen Y; Lu LM; Chen HZ; Zhu L
Cell Chem Biol; 2023 Jun; 30(6):591-605.e4. PubMed ID: 37263275
[TBL] [Abstract][Full Text] [Related]
69. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing.
Chen Q; Sun L; Chen ZJ
Nat Immunol; 2016 Sep; 17(10):1142-9. PubMed ID: 27648547
[TBL] [Abstract][Full Text] [Related]
70. Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer.
Loo TM; Miyata K; Tanaka Y; Takahashi A
Cancer Sci; 2020 Feb; 111(2):304-311. PubMed ID: 31799772
[TBL] [Abstract][Full Text] [Related]
71. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
[TBL] [Abstract][Full Text] [Related]
72. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
[TBL] [Abstract][Full Text] [Related]
73. cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma.
Tripathi S; Najem H; Mahajan AS; Zhang P; Low JT; Stegh AH; Curran MA; Ashley DM; James CD; Heimberger AB
F1000Res; 2022; 11():1010. PubMed ID: 36324813
[TBL] [Abstract][Full Text] [Related]
74. DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients.
Vasiyani H; Mane M; Rana K; Shinde A; Roy M; Singh J; Gohel D; Currim F; Srivastava R; Singh R
Apoptosis; 2022 Dec; 27(11-12):961-978. PubMed ID: 36018392
[TBL] [Abstract][Full Text] [Related]
75. PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer.
Shen D; Luo J; Chen L; Ma W; Mao X; Zhang Y; Zheng J; Wang Y; Wan J; Wang S; Ouyang J; Yi H; Liu D; Huang W; Zhang W; Liu Z; McLeod HL; He Y
Cancer Lett; 2022 Dec; 550():215919. PubMed ID: 36116741
[TBL] [Abstract][Full Text] [Related]
76. Targeting of the cGAS-STING system by DNA viruses.
Phelan T; Little MA; Brady G
Biochem Pharmacol; 2020 Apr; 174():113831. PubMed ID: 32004549
[TBL] [Abstract][Full Text] [Related]
77. The cGAS-STING Pathway in Bacterial Infection and Bacterial Immunity.
Liu N; Pang X; Zhang H; Ji P
Front Immunol; 2021; 12():814709. PubMed ID: 35095914
[TBL] [Abstract][Full Text] [Related]
78. [The Potential of a Novel Therapeutic Strategy for Colorectal Cancer Targeting the cGAS-STING Pathway].
Nakajima S; Kaneta A; Kono K
Gan To Kagaku Ryoho; 2023 Sep; 50(9):950-954. PubMed ID: 37800285
[TBL] [Abstract][Full Text] [Related]
79. cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers.
Ke X; Hu T; Jiang M
FASEB J; 2022 Jan; 36(1):e22029. PubMed ID: 34907606
[TBL] [Abstract][Full Text] [Related]
80. Discovery of CN0 as a novel proteolysis-targeting chimera (PROTAC) degrader of PARP1 that can activate the cGAS/STING immunity pathway combined with daunorubicin.
Lin S; Tu G; Yu Z; Jiang Q; Zhang L; Liu J; Liu Q; Huang X; Xu J; Lin Y; Liu Y; Wu L
Bioorg Med Chem; 2022 Sep; 70():116912. PubMed ID: 35830778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
